📊 SHFH Key Takeaways
Is Scientist Home Future Health Ltd (SHFH) a Good Investment?
SHFH is in severe financial distress with operating losses ($231.7K) that exceed total revenue ($204.1K), resulting in catastrophic negative cash burn of $323.1K annually. Liquidity is critically strained (current ratio 0.90x) with minimal cash reserves ($68.9K) against $531.0K liabilities, while the company continues capital expenditures despite fundamental unprofitability.
Scientist Home Future Health Ltd Key Strengths (SHFH)
- 40.1% gross margin demonstrates underlying product margin potential
- No long-term debt provides operational flexibility without debt servicing obligations
- Minimal revenue base growing at 3.3% YoY shows some market traction
SHFH Stock Risks: Scientist Home Future Health Ltd Investment Risks
- Operating cash flow negative $248.3K versus revenue of $204.1K indicates unsustainable burn rate
- Current ratio 0.90x and quick ratio 0.74x signal immediate liquidity crisis unable to cover near-term obligations
- Operating expenses exceed 250% of revenue with no clear path to profitability
- Free cash flow of negative $323.1K while stockholders equity is only $113.4K threatens solvency
- Ongoing $74.8K capital expenditures while unprofitable demonstrates poor capital allocation
- No insider activity in last 90 days suggests lack of management conviction
Key Metrics to Watch
- Operating cash flow trajectory toward positive territory
- Current ratio improvement and overall liquidity sustainability
- Operating expense reduction as percentage of revenue
Scientist Home Future Health Ltd (SHFH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
SHFH Profit Margin, ROE & Profitability Analysis
SHFH vs Consumer Sector: How Scientist Home Future Health Ltd Compares
How Scientist Home Future Health Ltd compares to Consumer sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Scientist Home Future Health Ltd Stock Overvalued? SHFH Valuation Analysis 2026
Based on fundamental analysis, Scientist Home Future Health Ltd has mixed fundamental signals relative to the Consumer sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Scientist Home Future Health Ltd Balance Sheet: SHFH Debt, Cash & Liquidity
SHFH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Scientist Home Future Health Ltd's revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $0.00 indicates the company is currently unprofitable.
SHFH Revenue Growth, EPS Growth & YoY Performance
SHFH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $44.8K | $6.1K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Scientist Home Future Health Ltd Dividends, Buybacks & Capital Allocation
SHFH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Scientist Home Future Health Ltd (CIK: 0002032609)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SHFH
What is the AI rating for SHFH?
Scientist Home Future Health Ltd (SHFH) has an AI grade of D with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SHFH's key strengths?
Claude: 40.1% gross margin demonstrates underlying product margin potential. No long-term debt provides operational flexibility without debt servicing obligations.
What are the risks of investing in SHFH?
Claude: Operating cash flow negative $248.3K versus revenue of $204.1K indicates unsustainable burn rate. Current ratio 0.90x and quick ratio 0.74x signal immediate liquidity crisis unable to cover near-term obligations.
What is SHFH's revenue and growth?
Scientist Home Future Health Ltd reported revenue of $204.1K.
Does SHFH pay dividends?
Scientist Home Future Health Ltd does not currently pay dividends.
Where can I find SHFH SEC filings?
Official SEC filings for Scientist Home Future Health Ltd (CIK: 0002032609) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SHFH's EPS?
Scientist Home Future Health Ltd has a diluted EPS of $-0.01.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is SHFH's fundamental grade?
Based on our AI fundamental analysis in June 2026, Scientist Home Future Health Ltd has a D grade with 95% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is SHFH stock overvalued or undervalued?
Valuation metrics for SHFH: ROE of -204.4% (sector avg: 18%), net margin of -113.6% (sector avg: 8%). Compare these metrics with sector averages to assess valuation.
What is SHFH's AI grade for 2026?
Our dual AI analysis gives Scientist Home Future Health Ltd a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SHFH's free cash flow?
Scientist Home Future Health Ltd's operating cash flow is $-248.3K, with capital expenditures of $74.8K. FCF margin is -158.3%.
How does SHFH compare to other Consumer stocks?
Vs Consumer sector averages: Net margin -113.6% (avg: 8%), ROE -204.4% (avg: 18%), current ratio 0.90 (avg: 1.5).